MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business Update
26 10월 2023 - 8:30PM
Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the
“Company” or “MindMed”), a clinical stage biopharmaceutical company
developing novel product candidates to treat brain health
disorders, announced today that it plans to host a conference call
on Thursday, November 2, 2023, at 4:30 p.m. ET to provide a
corporate update and review the Company’s results for the quarter
ended September 30, 2023.
Individuals may participate in the live call via telephone by
dialing (855) 327-6837 (domestic) or (631) 891-4304
(international). The webcast can be accessed live here on the
Financials page in the Investors section of the MindMed website,
https://mindmed.co/. The webcast will be archived on the Company’s
website for at least 30 days after the conference call.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders. Our
mission is to be the global leader in the development and delivery
of treatments that unlock new opportunities to improve patient
outcomes. We are developing a pipeline of innovative product
candidates, with and without acute perceptual effects, targeting
neurotransmitter pathways that play key roles in brain health
disorders.
MindMed trades on NASDAQ under the symbol MNMD and on the
Canadian NEO Exchange under the symbol MMED.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231026654127/en/
For Media & Investor Inquiries, please contact: Maxim
Jacobs, CFA Vice President, Investor Relations and Corporate
Communications Mind Medicine (MindMed) Inc. ir@mindmed.co
media@mindmed.co
Mind Medicine MindMed (NASDAQ:MNMD)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Mind Medicine MindMed (NASDAQ:MNMD)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
